申请人:Fujisawa Deutschland GmbH
公开号:EP1348434A1
公开(公告)日:2003-10-01
The invention relates to the use of derivatives of Formula I in the manufacture of a pharmaceutical composition for the treatment of a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred, and to the prevention thereof.
本发明涉及使用公式I的衍生物制备药物组合物,用于治疗哺乳动物中发生了不合适、过度或不良的血管生成,并防止其发生。